{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:02:07Z","timestamp":1780534927818,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"DOI":"10.1186\/s13321-026-01204-7","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T19:09:54Z","timestamp":1776712194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ChemScreener: an active learning enabled hit discovery workflow with WDR5 inhibitor case study"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3925-7479","authenticated-orcid":false,"given":"Lingling","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy L.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4144-9122","authenticated-orcid":false,"given":"He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"1204_CR1","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/0959-440X(94)90268-2","volume":"4","author":"PM Colman","year":"1994","unstructured":"Colman PM (1994) Structure-based drug design. Curr Opin Struct Biol 4:868\u2013874. https:\/\/doi.org\/10.1016\/0959-440X(94)90268-2","journal-title":"Curr Opin Struct Biol"},{"key":"1204_CR2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/s43588-024-00697-2","volume":"4","author":"D van Tilborg","year":"2024","unstructured":"van Tilborg D, Grisoni F (2024) Traversing chemical space with active deep learning for low-data drug discovery. Nat Comput Sci 4:786\u2013796. https:\/\/doi.org\/10.1038\/s43588-024-00697-2","journal-title":"Nat Comput Sci"},{"key":"1204_CR3","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.drudis.2014.12.004","volume":"20","author":"D Reker","year":"2015","unstructured":"Reker D, Schneider G (2015) Active-learning strategies in computer-assisted drug discovery. Drug Discov Today 20:458\u2013465. https:\/\/doi.org\/10.1016\/j.drudis.2014.12.004","journal-title":"Drug Discov Today"},{"key":"1204_CR4","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1039\/D0SC06805E","volume":"12","author":"DE Graff","year":"2021","unstructured":"Graff DE, Shakhnovich EI, Coley CW (2021) Accelerating high-throughput virtual screening through molecular pool-based active learning. Chem Sci 12:7866\u20137881. https:\/\/doi.org\/10.1039\/D0SC06805E","journal-title":"Chem Sci"},{"key":"1204_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ddtec.2020.06.001","volume":"32\u201333","author":"D Reker","year":"2019","unstructured":"Reker D (2019) Practical considerations for active machine learning in drug discovery. Drug Discov Today Technol 32\u201333:73\u201379. https:\/\/doi.org\/10.1016\/j.ddtec.2020.06.001","journal-title":"Drug Discov Today Technol"},{"key":"1204_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/0092-8674(92)90602-9","volume":"71","author":"DC Tkachuk","year":"1992","unstructured":"Tkachuk DC, Kohler S, Cleary ML (1992) Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71:691\u2013700. https:\/\/doi.org\/10.1016\/0092-8674(92)90602-9","journal-title":"Cell"},{"key":"1204_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nrc3929","volume":"15","author":"RC Rao","year":"2015","unstructured":"Rao RC, Dou Y (2015) Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. Nat Rev Cancer 15:334\u2013346. https:\/\/doi.org\/10.1038\/nrc3929","journal-title":"Nat Rev Cancer"},{"key":"1204_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2017.00004","volume":"5","author":"AC Winters","year":"2017","unstructured":"Winters AC, Bernt KM (2017) MLL-rearranged leukemias\u2014an update on science and clinical approaches. Front Pediatr 5:4. https:\/\/doi.org\/10.3389\/fped.2017.00004","journal-title":"Front Pediatr"},{"key":"1204_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/2516865719865282","volume":"12","author":"ER Aho","year":"2019","unstructured":"Aho ER, Weissmiller AM, Fesik SW, Tansey WP (2019) Targeting WDR5: a winning anti-cancer strategy? Epigenetics Insights 12:2516865719865282. https:\/\/doi.org\/10.1177\/2516865719865282","journal-title":"Epigenetics Insights"},{"key":"1204_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7020021","volume":"7","author":"AD Guarnaccia","year":"2018","unstructured":"Guarnaccia AD, Tansey WP (2018) Moonlighting with WDR5: a cellular multitasker. J Clin Med 7:21. https:\/\/doi.org\/10.3390\/jcm7020021","journal-title":"J Clin Med"},{"key":"1204_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nature16952","volume":"530","author":"Y Li","year":"2016","unstructured":"Li Y, Han J, Zhang Y, Cao F, Liu Z, Li S, Wu J, Hu C, Wang Y, Shuai J, Chen J, Cao L, Li D, Shi P, Tian C, Zhang J, Dou Y, Li G, Chen Y, Lei M (2016) Structural basis for activity regulation of MLL family methyltransferases. Nature 530:447\u2013452. https:\/\/doi.org\/10.1038\/nature16952","journal-title":"Nature"},{"key":"1204_CR12","doi-asserted-by":"publisher","first-page":"22357","DOI":"10.1074\/jbc.M116.752626","volume":"291","author":"NL Alicea-Velazquez","year":"2016","unstructured":"Alicea-Velazquez NL, Shinsky SA, Loh DM, Lee JH, Skalnik DG, Cosgrove MS (2016) Targeted disruption of the interaction between WD-40 repeat protein 5 (WDR5) and mixed lineage leukemia (MLL)\/SET1 family proteins specifically inhibits MLL1 and SETd1A methyltransferase complexes. J Biol Chem 291:22357\u201322362. https:\/\/doi.org\/10.1074\/jbc.M116.752626","journal-title":"J Biol Chem"},{"key":"1204_CR13","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1021\/acs.jmedchem.6b01796","volume":"60","author":"H Karatas","year":"2017","unstructured":"Karatas H, Li Y, Liu L, Ji J, Lee S, Chen Y, Yang J, Huang L, Bernard D, Xu J, Townsend EC, Cao F, Ran X, Li X, Wen B, Sun D, Stuckey JA, Lei M, Dou Y, Wang S (2017) Discovery of a highly potent, cell-permeable macrocyclic peptidomimetic (MM-589) targeting the WD repeat domain 5 protein (WDR5)-mixed lineage leukemia (MLL) protein-protein interaction. J Med Chem 60:4818\u20134839. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01796","journal-title":"J Med Chem"},{"key":"1204_CR14","doi-asserted-by":"publisher","first-page":"10537","DOI":"10.1021\/acs.jmedchem.1c00037","volume":"64","author":"X Chen","year":"2021","unstructured":"Chen X, Xu J, Wang X, Long G, You Q, Guo X (2021) Targeting WD repeat-containing protein 5 (WDR5): A medicinal chemistry perspective. J Med Chem 64:10537\u201310556. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00037","journal-title":"J Med Chem"},{"key":"1204_CR15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1021\/acschembio.3c00108","volume":"18","author":"L Liu","year":"2023","unstructured":"Liu L, Shen L, Ding Z et al (2023) Mechanism of resistance to the WDR5 inhibitor in MLL-rearranged leukemia. ACS Chem Biol 18:949\u2013958. https:\/\/doi.org\/10.1021\/acschembio.3c00108","journal-title":"ACS Chem Biol"},{"key":"1204_CR16","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1021\/acs.jcim.9b00237","volume":"59","author":"K Yang","year":"2019","unstructured":"Yang K, Swanson K, Jin W et al (2019) Analyzing learned molecular representations for property prediction. J Chem Inf Model 59:3370\u20133388. https:\/\/doi.org\/10.1021\/acs.jcim.9b00237","journal-title":"J Chem Inf Model"},{"key":"1204_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1021\/acs.jcim.3c01250","volume":"64","author":"E Heid","year":"2024","unstructured":"Heid E, Greenman KP, Chung Y et al (2024) Chemprop: A machine learning package for chemical property prediction. J Chem Inf Model 64:9\u201317. https:\/\/doi.org\/10.1021\/acs.jcim.3c01250","journal-title":"J Chem Inf Model"},{"key":"1204_CR18","unstructured":"Falcon WA (2019) Pytorch lightning. GitHub ; 3"},{"key":"1204_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1021\/c160017a018","volume":"5","author":"HL Morgan","year":"1965","unstructured":"Morgan HL (1965) The generation of a unique machine description for chemical structures\u2014a technique developed at chemical abstracts service. J Chem Doc 5:107\u2013113. https:\/\/doi.org\/10.1021\/c160017a018","journal-title":"J Chem Doc"},{"key":"1204_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1613\/jair.614","volume":"11","author":"D Opitz","year":"1999","unstructured":"Opitz D, Maclin R (1999) Popular ensemble methods: an empirical study. J Artif Intell Res 11:169\u2013198. https:\/\/doi.org\/10.1613\/jair.614","journal-title":"J Artif Intell Res"},{"key":"1204_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1109\/MCAS.2006.1688199","volume":"6","author":"R Polikar","year":"2006","unstructured":"Polikar R (2006) Ensemble based systems in decision making. IEEE Circuits Syst Mag 6:21\u201345. https:\/\/doi.org\/10.1109\/MCAS.2006.1688199","journal-title":"IEEE Circuits Syst Mag"},{"key":"1204_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10462-009-9124-7","volume":"33","author":"L Rokach","year":"2010","unstructured":"Rokach L (2010) Ensemble-based classifiers. Artif Intell Rev 33:1\u201339. https:\/\/doi.org\/10.1007\/s10462-009-9124-7","journal-title":"Artif Intell Rev"},{"key":"1204_CR23","unstructured":"RDKit (2024) Open-source cheminformatics. https:\/\/www.rdkit.org"},{"key":"1204_CR24","unstructured":"Paszke A, Gross S, Massa F, Lerer A, Bradbury J, Chanan G, Killeen T, Lin Z, Gimelshein N, Antiga L, Desmaison A (2019) Pytorch: An imperative style, high-performance deep learning library. Advances in neural information processing systems.;32."},{"issue":"153","key":"1204_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107849","volume":"1","author":"SR Shetty","year":"2024","unstructured":"Shetty SR, Debnath S, Majumdar K, Rajagopalan M, Ramaswamy A, Das A (2024) Virtual screening, molecular dynamics simulations, and in vitro validation of EGFR inhibitors as breast cancer therapeutics. Bioorgan Chem 1(153):107849","journal-title":"Bioorgan Chem"},{"key":"1204_CR26","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.3762\/bjoc.20.185","volume":"20","author":"Z Fralish","year":"2024","unstructured":"Fralish Z, Reker D (2024) Finding the most potent compounds using active learning on molecular pairs. Beilstein J Org Chem 20:2152\u20132162. https:\/\/doi.org\/10.3762\/bjoc.20.185","journal-title":"Beilstein J Org Chem"},{"key":"1204_CR27","unstructured":"Houlsby N, Husz\u00e1r F, Ghahramani Z, Lengyel M 2011 Bayesian active learning for classification and preference learning. arXiv preprint arXiv:1112.5745"},{"key":"1204_CR28","first-page":"2579","volume":"9","author":"L Van der Maaten","year":"2008","unstructured":"Van der Maaten L, Hinton G (2008) Visualizing data using t-SNE. J Mach Learn Res 9:2579\u20132605","journal-title":"J Mach Learn Res"},{"key":"1204_CR29","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1021\/jm9602928","volume":"39","author":"GW Bemis","year":"1996","unstructured":"Bemis GW, Murcko MA (1996) The properties of known drugs. 1. molecular frameworks. J Med Chem 39:2887\u20132893. https:\/\/doi.org\/10.1021\/jm9602928","journal-title":"J Med Chem"},{"key":"1204_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326. https:\/\/doi.org\/10.1016\/S0169-409X(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"key":"1204_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1:337\u2013341. https:\/\/doi.org\/10.1016\/j.ddtec.2004.11.007","journal-title":"Drug Discov Today Technol"},{"key":"1204_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1023\/A:1008763014207","volume":"18","author":"I Massova","year":"2000","unstructured":"Massova I, Kollman PA (2000) Combined molecular mechanical and continuum solvent approach (MM-PBSA\/GBSA) to predict ligand binding. Perspect Drug Discov Des 18:113\u2013135. https:\/\/doi.org\/10.1023\/A:1008763014207","journal-title":"Perspect Drug Discov Des"},{"key":"1204_CR33","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"PA Kollman","year":"2000","unstructured":"Kollman PA, Massova I, Reyes C et al (2000) Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 33:889\u2013897. https:\/\/doi.org\/10.1021\/ar000033j","journal-title":"Acc Chem Res"},{"key":"1204_CR34","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1016\/j.celrep.2019.02.047","volume":"26","author":"ER Aho","year":"2019","unstructured":"Aho ER, Wang J, Gogliotti RD et al (2019) Displacement of WDR5 from chromatin by a WIN site inhibitor with picomolar affinity. Cell Rep 26:2916\u20132928. https:\/\/doi.org\/10.1016\/j.celrep.2019.02.047","journal-title":"Cell Rep"},{"key":"1204_CR35","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1021\/jm060522a","volume":"49","author":"PD Lyne","year":"2006","unstructured":"Lyne PD, Lamb ML, Saeh JC (2006) Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. J Med Chem 49:4805\u20134808. https:\/\/doi.org\/10.1021\/jm060522a","journal-title":"J Med Chem"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13321-026-01204-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-026-01204-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-026-01204-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:08:41Z","timestamp":1780531721000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13321-026-01204-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1204"],"URL":"https:\/\/doi.org\/10.1186\/s13321-026-01204-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2025-0c4mm","asserted-by":"object"}]},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors are past or current employees of Novartis. The authors declare no other competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}